Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New wireless system aims to spot hospital patients getting worse faster

NCT ID NCT07451249

Knowledge-focused Sponsor: Eske Kvanner Aasvang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how hospitals in Europe currently monitor patients and tests a new wireless system called WARD-CSS. The system continuously tracks breathing and heart signals to catch signs of decline earlier. About 1,240 adults staying in the hospital for at least two days will take part. The goal is to see if the system is easy to use and helps doctors and nurses respond faster.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,240 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years) admitted to hospitals due to medical or surgical conditions with an expected hospital stay of at least two days. * Adults discharged from the hospital who are receiving home-based monitoring using WARD-CSS (Phase 2 only). * Willingness to participate and provide informed consent. Exclusion Criteria: * Patients with severe comorbidities (e.g., severe dementia) that preclude continuous monitoring. * Patients unwilling or unable to provide informed consent. * Patients unable to wear the monitoring equipment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical deterioration are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Clinical Deterioration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clinical deterioration Patient deterioration Patient monitoring

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites in 4 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bispebjerg hospital

    Copenhagen, 2400, Denmark

  • Jagiellonian University Medical College

    Krakow, 31008, Poland

  • NOVA Medical School

    Lisbon, 1169-056, Portugal

  • Rigshospitalet

    Copenhagen, Capital Region, 2100, Denmark

  • University Medical Center Groningen

    Groningen, 9713, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.